Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma.
about
Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy)Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease.MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotypeAsthma mediators: current views.Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthmaHyaluronan as an immune regulator in human diseases.Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma.Role of hyaluronan and hyaluronan-binding proteins in human asthma.Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy.Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy.Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.Aggravation of Allergic Airway Inflammation by Cigarette Smoke in Mice Is CD44-Dependent.Hyaluronan and Its Heavy Chain Modification in Asthma Severity and Experimental Asthma Exacerbation.Correlation of hyaluronan deposition with infiltration of eosinophils and lymphocytes in a cockroach-induced murine model of asthma.TSG-6 protein is crucial for the development of pulmonary hyaluronan deposition, eosinophilia, and airway hyperresponsiveness in a murine model of asthma.Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid.Hyaluronan as a therapeutic target in human diseasesEosinophils in vasculitis: characteristics and roles in pathogenesis.Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells.Extracellular matrix and airway smooth muscle interactions: a target for modulating airway wall remodelling and hyperresponsiveness?Subepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma.Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrixWhat's new in asthma pathophysiology and immunopathology?Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?Interplay of extracellular matrix and leukocytes in lung inflammation.Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle.Soluble markers of allergic inflammation.Bronchoalveolar lavage in asthma. An update and perspective.Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD.Inflammatory markers in childhood asthma.Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.cDNA cloning and substrate specificity of equine tryptase, a possible mediator in equine heaves.Hyaluronan fragments contribute to the ozone-primed immune response to lipopolysaccharide.Evaluation of serum eosinophil cationic protein as a predictive marker for asthma exacerbation in patients with persistent disease.Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease.A novel role for primary cilia in airway remodeling.beta1-Integrins mediate enhancement of airway smooth muscle proliferation by collagen and fibronectin.Targeted HAS2 Expression Lessens Airway Responsiveness in Chronic Murine Allergic Airway Disease.
P2860
Q28288938-15EFE73A-3D23-4A2A-AE34-C173B032B8D0Q33723690-7427C3EA-D326-409D-A91B-06C5062A2ACCQ33766443-33D1E4F1-8995-492A-906B-6ED74A90A4F8Q33861545-37D07552-C545-4632-A344-F4299BAF4150Q34127022-A1639B8A-518E-412F-82B9-A77B71D84863Q34154042-64492D54-BFA5-45BE-A38C-E45D16F1D8C9Q34636380-03D02B07-B35F-481E-9510-927C70261616Q34997150-1F747975-9641-4E49-9459-C0AA75BE5C6DQ35146157-70DCF6C0-84D7-4904-B900-CCD11F6BABF8Q35149020-89B742CA-B7A4-4331-92B6-C32D310D4B02Q35357190-4504C883-678E-4F4E-A269-58055F45DF1CQ35533314-033FA620-ECF0-4D85-AA95-D95E2A6CDBA3Q35964861-0491A67F-E001-4D56-A1C9-79D12C946125Q36281626-0278D456-DA71-4F80-881B-C4E71B4D398CQ36419351-A32363CA-FA43-4DFA-B3DA-9227196DF9C6Q36508659-17DC3887-B84D-40F6-9DCE-30C059291C4EQ36548420-C16F8ECB-FB31-4B7D-84DA-82F675BDCB93Q36578627-959919F4-8F62-450B-B6BF-A7AD928BF6C3Q36847447-E54C1A03-AED5-40A2-BB29-1CE71E6B2DB9Q36880796-1B452336-6A01-44D0-98DB-44C4F377390EQ36933209-6CEDDCCB-2FA9-4428-BB9E-FE8B7C8B5D80Q36954958-3D9D99FE-8A13-484A-AB2D-D4B0C1DBEA15Q37099180-FABD3AC9-A288-4A7F-A19B-169F95E066A2Q37798030-92F794C9-1FCD-4876-B519-A759F68CB121Q37909907-1E02022F-C88A-4747-BB3D-FBF9220D363AQ39080263-7A8F6AC8-EA89-48C9-A96F-70B79B7F7535Q39780799-FAE571EE-0DBA-49F5-8E2F-754A70402D48Q40485763-DEFE6BA9-F812-461E-A875-20FACF746F3DQ40759554-4A28111E-E713-42E2-882A-4EF6277EA67CQ40830813-3169D3E7-E614-4A26-AA56-63A5EFB379C6Q41207792-F505C37C-5854-4535-AE1B-CE6190695BBDQ41250324-7E043315-B651-47E0-B47E-5E33EA893FB7Q42553057-EDB75380-AF20-4978-8A36-AEB62DDA2A04Q42599742-C656A824-BBBB-43BC-B8CF-E69249521A12Q42841374-564C097B-9D59-41E1-BC7C-CADF40380283Q44130774-7AB5BF3A-0FB9-46D7-A227-7A5BDE597BE1Q44918184-3510ECBE-AA1C-4050-8F06-B49B0AC6C139Q45058431-269CFFD9-B83B-430E-96D1-761990021BFAQ45122173-5FBD2D42-2A98-49B9-9AFC-8DBBE01058E6Q47673465-1D1EAF5C-069E-4D60-95EA-8D1F1DECBFC5
P2860
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Indirect evidence of bronchial ...... fluid of patients with asthma.
@en
Indirect evidence of bronchial ...... fluid of patients with asthma.
@nl
type
label
Indirect evidence of bronchial ...... fluid of patients with asthma.
@en
Indirect evidence of bronchial ...... fluid of patients with asthma.
@nl
prefLabel
Indirect evidence of bronchial ...... fluid of patients with asthma.
@en
Indirect evidence of bronchial ...... fluid of patients with asthma.
@nl
P2093
P921
P1476
Indirect evidence of bronchial ...... fluid of patients with asthma.
@en
P2093
Ahlstedt S
Bousquet J
Lacoste JY
Peterson C
P304
P356
10.1016/0091-6749(91)90159-L
P407
P577
1991-10-01T00:00:00Z